(Q46465274)

22 December 2017

title

Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium (English)

1 reference

22 December 2017

main subject

endometrial hyperplasia

1 reference

1 reference

Francisco J Orejuela

1

1 reference

22 December 2017

Lois M Ramondetta

2

1 reference

22 December 2017

Judith Smith

3

1 reference

22 December 2017

Jubilee Brown

4

1 reference

22 December 2017

Luciano B Lemos

5

1 reference

22 December 2017

Yang Li

6

1 reference

22 December 2017

Lisa M Hollier

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

97

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

483-488

1 reference

22 December 2017

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Two pathogenetic types of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Serum fatty acids and breast cancer incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Dietary fat, fatty acids and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Non-steroidal anti-inflammatory drugs and prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Review article: cyclooxygenase--a target for colon cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of cyclooxygenase-2 in prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of cyclo-oxygenase in human endometrium during the implantation period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Cyclooxygenase-2 and chemoprevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Breast cancer prevention—clinical trials strategies involving aromatase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Expression of enzyme associated with steroid hormone synthesis and local production of steroid hormone in endometrial carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

Aspirin use and reduced risk of fatal colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.02.010

10.1016/J.YGYNO.2005.02.010

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017